Literature DB >> 33190739

Non-response did not affect prevalence estimates of asthma and respiratory symptoms - results from a postal questionnaire survey of the general population.

P Räisänen1, L Hedman2, M Andersson3, C Stridsman3, A Lindberg4, B Lundbäck5, E Rönmark3, H Backman2.   

Abstract

BACKGROUND: A high participation rate is warranted in order to ensure validity in surveys of the general population. However, participation rates in such studies have declined during the last decades.
OBJECTIVE: To evaluate the reasons for and potential effects of non-response in a large population-based survey about asthma and respiratory symptoms in Northern Sweden.
METHODS: Within the Obstructive Lung Disease In Norrbotten (OLIN) studies, a random sample of 12,000 adults aged 20-79 was invited to a postal questionnaire survey about asthma, allergic rhino-conjunctivitis and respiratory symptoms in 2016. Three reminders were sent. A random sample of 500 non-responders was invited to a telephone interview.
RESULTS: The participation rate in the initial mailing was 41.4%, and 9.2%, 5.0%, and 2.6% in the subsequent three reminders and totally 58.3% (n = 6854) responded. Of 500 non-responders selected for telephone interviews, 320 were possible to reach and 272 participated. Male sex, younger age, and current smoking were associated with both late and non-response. The prevalence of asthma and most respiratory symptoms did not differ significantly between responders and non-responders while allergic rhino-conjunctivitis and smoking was more common among non-responders. Reminders increased the participation rate but did not alter risk ratios for smoking and occupational exposures. Reasons for non-response were mainly lack of time and having forgotten to answer.
CONCLUSIONS: With a response rate of 58.3%, neither the prevalence estimates of asthma, respiratory symptoms nor the associations to risk factors were affected by non-response, while allergic rhino-conjunctivitis and smoking was underestimated in this Swedish population.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Non-response; Participation rate; Population survey; Respiratory epidemiology

Mesh:

Year:  2020        PMID: 33190739     DOI: 10.1016/j.rmed.2020.106017

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  5 in total

1.  Factors Associated with Survey Non-Response in a Cross-Sectional Survey of Persons with an Axial Spondyloarthritis or Osteoarthritis Claims Diagnosis.

Authors:  Johanna Callhoff; Hannes Jacobs; Katinka Albrecht; Joachim Saam; Angela Zink; Falk Hoffmann
Journal:  Int J Environ Res Public Health       Date:  2020-12-09       Impact factor: 3.390

2.  NSAID-exacerbated respiratory disease: a population study.

Authors:  Heidi Andersén; Pinja Ilmarinen; Jasmin Honkamäki; Leena E Tuomisto; Hanna Hisinger-Mölkänen; Helena Backman; Bo Lundbäck; Eva Rönmark; Tari Haahtela; Anssi Sovijärvi; Lauri Lehtimäki; Päivi Piirilä; Hannu Kankaanranta
Journal:  ERJ Open Res       Date:  2022-01-24

3.  Influence of Childhood Exposure to a Farming Environment on Age at Asthma Diagnosis in a Population-Based Study.

Authors:  Heidi Andersén; Pinja Ilmarinen; Jasmin Honkamäki; Leena E Tuomisto; Hanna Hisinger-Mölkänen; Helena Backman; Bo Lundbäck; Eva Rönmark; Lauri Lehtimäki; Anssi Sovijärvi; Päivi Piirilä; Hannu Kankaanranta
Journal:  J Asthma Allergy       Date:  2021-09-07

4.  Restrictive spirometry versus restrictive lung function using the GLI reference values.

Authors:  Tomi Myrberg; Anne Lindberg; Berne Eriksson; Linnea Hedman; Caroline Stridsman; Bo Lundbäck; Eva Rönmark; Helena Backman
Journal:  Clin Physiol Funct Imaging       Date:  2022-02-28       Impact factor: 2.121

5.  The combined effect of exposures to vapours, gases, dusts, fumes and tobacco smoke on current asthma.

Authors:  Hanna Hisinger-Mölkänen; Hannu Kankaanranta; Tari Haahtela; Anssi Sovijärvi; Leena Tuomisto; Heidi Andersén; Ari Lindqvist; Helena Backman; Arnulf Langhammer; Eva Rönmark; Pinja Ilmarinen; Paula Pallasaho; Päivi Piirilä
Journal:  Clin Respir J       Date:  2022-06-10       Impact factor: 1.761

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.